Marshall I Hertz
Overview
Explore the profile of Marshall I Hertz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
2938
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martin C, Mahan K, Wiggen T, Gilbertsen A, Hertz M, Hunter R, et al.
Microbiome
. 2024 Oct;
12(1):196.
PMID: 39385282
Background: Progression of chronic lung disease may lead to the requirement for lung transplant (LTx). Despite improvements in short-term survival after LTx, chronic lung allograft dysfunction (CLAD) remains a critical...
2.
Van Raemdonck D, Keshavjee S, Levvey B, Cherikh W, Snell G, Erasmus M, et al.
J Heart Lung Transplant
. 2019 Nov;
38(12):1235-1245.
PMID: 31777330
Background: This study aimed to examine intermediate-term outcomes of lung transplantation (LTx) recipients from donors after circulatory death (DCD). Methods: We examined the International Society for Heart and Lung Transplantation...
3.
Loor G, Warnecke G, Villavicencio M, Smith M, Kukreja J, Ardehali A, et al.
Lancet Respir Med
. 2019 Aug;
7(11):975-984.
PMID: 31378427
Background: Donor lung use for transplantation is the lowest among solid organ tranplants because of several complex and multifactorial reasons; one area that could have a substantial role is the...
4.
Spratt J, Brown R, Rudser K, Goswami U, Hertz M, Patil J, et al.
J Thorac Dis
. 2019 Jun;
11(4):1130-1144.
PMID: 31179055
Background: Alpha-1-antitrypsin (A1AT) deficiency (A1ATD) is characterized by accelerated degradation of lung function. We examined our experience with lung transplantation for chronic obstructive pulmonary disease (COPD) with and without A1ATD...
5.
Tomic R, Hertz M
Curr Opin Organ Transplant
. 2018 Apr;
23(3):324-329.
PMID: 29629993
Purpose Of Review: The purpose of this review is to review recent literature related to mechanisms and treatment options for 'secondary' (i.e., WHO Groups 3 and 5) pulmonary arterial hypertension...
6.
Van Raemdonck D, Hartwig M, Hertz M, Davis R, Cypel M, Hayes Jr D, et al.
J Heart Lung Transplant
. 2017 Aug;
36(10):1121-1136.
PMID: 28784325
No abstract available.
7.
Holley C, Kelly R, Shumway S, Brown R, Hertz M, Rudser K, et al.
J Thorac Cardiovasc Surg
. 2017 Jul;
154(6):2126-2133.e2.
PMID: 28712587
Background: We sought to clarify the effect of donor age as a continuous variable on morbidity and mortality in a single-institution experience. Methods: From 1986 to 2016, 882 adult lung...
8.
Spratt J, Shrestha P, Loor G, Patil J, Hertz M, Pettersson G, et al.
Innovations (Phila)
. 2017 May;
12(3):214-216.
PMID: 28538271
A 53-year-old woman who underwent bilateral lung transplantation 14 months before presented with 2 to 3 weeks of severe exertional dyspnea. Workup revealed a complete embolic occlusion of her left...
9.
Loor G, Brown R, Kelly R, Rudser K, Shumway S, Cich I, et al.
Clin Transplant
. 2016 Dec;
31(3).
PMID: 27988981
The purpose of this study was to clarify the significance of recipient gender status on lung transplant outcomes in a large single-institution experience spanning three decades, we analyzed data from...
10.
Taimeh Z, Hertz M, Shumway S, Pritzker M
Thorax
. 2016 Jan;
71(4):378-9.
PMID: 26781176
Objective: Lung transplantation is the ultimate treatment for end-stage pulmonary sarcoidosis. Post-transplant survival outcomes remain unclear. Methods: Survival models were used to assess survival and graft outcomes in patients with...